NCT06923423

Brief Summary

Addiction and trauma exposure are common among the 5.5 million people (1 in 47 adults) in the U.S. who are in prison or under supervision. About 85% of people in prison have a substance use disorder or are there for a drug-related crime, and many have experienced serious trauma before being incarcerated. Posttraumatic stress symptoms (PTSS) are often a result of trauma and are linked to more severe drug use, higher rates of relapse, and increased crime. PTSS and substance use disorder (SUD) each raise the chances of new arrests for people who are justice-involved, showing that addressing trauma and addiction could help reduce repeat offenses and the costs of incarceration. However, treatments for PTSS are rarely available in prisons, and there is little research on whether providing therapy for PTSS in prison can lower drug use, PTSS, or crime after release. The goal of this clinical trial is to see if trauma-focused group therapy (CPT) provided while in prison, can help people after release from prison. The therapy has been adapted for use in prisons (CPT-CJ) and will be compared to trauma focused therapy delivered via a self-help workbook This study will:

  • test whether a trauma-focused group therapy (CPT-CJ) can reduce post-incarceration drug and alcohol use, mental health issues, and drug-related crime, compared to trauma-focused self-help,
  • evaluate a strategy called implementation facilitation, which helps support the use of this therapy in prisons, and
  • measure the cost of the therapies and support strategies to help plan for future expansion. Incarcerated participants (N = 640; 50% female) will be enrolled from \~10 prisons in \~5 states, ensuring variability in population and setting characteristics. They will:
  • take surveys and answer questions up to 5 times (before starting treatment, right after getting treatment, right before leaving prison, 3 months after leaving prison and 6 months after leaving prison)
  • complete CPT group therapy or self-help therapy
  • provide urine samples 3 months and 6 months after leaving prison Prison stakeholders (e.g., prison staff, prison leadership, governmental officials; N = \~15 per site) who will be purposively sampled based on their role in CPT-CJ implementation will also participate in some surveys.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
640

participants targeted

Target at P75+ for not_applicable

Timeline
31mo left

Started Jul 2025

Longer than P75 for not_applicable

Geographic Reach
1 country

6 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress25%
Jul 2025Dec 2028

First Submitted

Initial submission to the registry

February 3, 2025

Completed
2 months until next milestone

First Posted

Study publicly available on registry

April 11, 2025

Completed
3 months until next milestone

Study Start

First participant enrolled

July 7, 2025

Completed
3.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2028

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2028

Last Updated

January 21, 2026

Status Verified

January 1, 2026

Enrollment Period

3.4 years

First QC Date

February 3, 2025

Last Update Submit

January 20, 2026

Conditions

Keywords

Post traumatic Stress DisorderPost traumatic Stress SymptomsSubstance UseSubstance Use DisorderCognitive Processing TherapyCognitive Processing Therapy for Criminal Justice SettingTrauma focused self helpFacilitationImplementation FacilitationImplementationCost Estimation and OffsetsDrug Use DisorderAlcohol Use DisorderTraumaDepressionAdultIncarceratedPrisonImprisonmentInterventionTreatment ComparisonAcceptabilityFeasibilityBudget ImpactCost EstimateImplementation EvaluationRecidivismSelf HelpWorkbookCriminal JusticeEffectivenessEvidence Based InterventionCPTCPT-CJ

Outcome Measures

Primary Outcomes (4)

  • Drug Use Frequency (Count)

    Participants complete a Timeline Follow Back Interview assessment of illicit drug use during the previous 30 days at 3- \& 6-months post-release from prison. The total number of days of drug use will be summed to represent drug use frequency.

    3- and 6-month post-release from prison

  • Drug use (Binary)

    Participants complete a Timeline Follow Back Interview assessment of illicit drug use during the previous 30 days at 3- \& 6-months post-release from prison. The total number of days of drug use will be dichotomized to indicate presence or absence of drug use since release.

    3- and 6-month post-release from prison

  • Posttraumatic Stress Symptom Severity (Sum)

    Participants complete the PTSD Checklist for DSM-5 (PCL-5) at all assessments to examine change the effectiveness of the intervention and control groups on posttraumatic stress symptom severity. Scores range from 0-80 with higher scores indicating more severe PTSD symptoms.

    Pre-treatment assessments will be ~2 wks before tx starts; post-treatment will be ~2 wks after tx ends; pre-release will be ~3 days before release; post-release follow-ups will be 3- and 6-mo after prison exist

  • Treatment fidelity (ratio)

    The ratio of the number of CPT-CJ components delivered to the number of CPT-CJ components planned per completed fidelity monitoring templates.

    Fidelity assessments will be done during the active treatment period which can be as short as 6 weeks to as long as 3 months for participants. The active treatment period is expected to span 1.5 years at each site.

Secondary Outcomes (18)

  • Drug Use Disorder Symptom Severity (Count)

    3- and 6-months post-release from prison

  • Drug Use Disorder (Binary)

    3- and 6-months post-release from prison

  • Depressive Symptom Severity (Sum)

    Pre-treatment assessments will be done ~2 wks before tx starts; post-treatment will be ~2 wks after tx ends; pre-release will be ~3 days before release; post-release follow-ups will be ~3- and ~6-mo after prison exit

  • Alcohol Use Frequency (Count)

    3- and 6-months post-release from prison

  • Alcohol Use (Binary)

    3- and 6-months post-release from prison

  • +13 more secondary outcomes

Study Arms (2)

Group Cognitive Processing Therapy (CPT)

ACTIVE COMPARATOR

Participants in CPT group therapy will learn about trauma and how to change upsetting thoughts related to it. Participants will attend up to a total of 12 sessions held 1-2x/week for 90 minutes. No more than 10 participants will be in a group. In this study, CPT provided is a version that was adapted for prisons (CPT-CJ).

Behavioral: Group Cognitive Processing Therapy (CPT)

Individual trauma focused self-help via workbook

ACTIVE COMPARATOR

Participants in the trauma-focused self-help therapy will independently read and do practice assignments in a workbook to learn skills to recover from trauma.

Behavioral: Control Group Individual trauma focused self-help via workbook

Interventions

Participants in CPT group therapy will learn about trauma and how to change upsetting thoughts related to it. Participants will attend up to a total of 12 sessions held 1-2x/week for 90 minutes. No more than 10 participants will be in a group. In this study, CPT provided is a version that was adapted for prisons.

Also known as: CPT-CJ
Group Cognitive Processing Therapy (CPT)

The self-help therapy is a therapy that people do on their own using a workbook. By reading and doing practice assignments in the workbook, people can learn skills to recover from trauma.

Individual trauma focused self-help via workbook

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • years of age or older
  • Able to understand and speak English
  • Able to give informed consent
  • Be currently incarcerated in one of the prisons that have partnered as study sites
  • Have met criteria for a drug use disorder in the year prior to their current incarceration (≥ 2 symptoms on a DSM-5 drug use disorder checklist)
  • Have used drugs in the 30 days prior to their current incarceration
  • Have a history of traumatic event exposure
  • Endorse clinically significant posttraumatic stress symptoms (score ≥ 4 on the Primary Care PTSD Screen for DSM-5; PC-PTSD-5)
  • Expect to be incarcerated for at least long enough to complete CPT-CJ as it is being implemented at the particular site (i.e., anticipated to be \~3 months, but will depend on dates associated with next available intervention group)
  • Expect to be released from prison within 12 months following the end of treatment (i.e., within \~15 months of the pre-treatment assessment)
  • Willing to consent to randomization to treatment condition

You may not qualify if:

  • Unable to provide any locator information for post-release assessments
  • Determined to be releasing sooner than would allow the individual to complete CPT-CJ

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (6)

University of Arkansas for Medical Sciences

Little Rock, Arkansas, 72205, United States

NOT YET RECRUITING

Northeast Arkansas Community Corrections Center (NEACC)

Osceola, Arkansas, 72370, United States

RECRUITING

Southwest Arkansas Community Correction Center

Texarkana, Arkansas, 71854, United States

RECRUITING

East Central Arkansas Community Correction Center

West Memphis, Arkansas, 72301, United States

RECRUITING

North Dakota State Penitentiary (NDSP)

Bismarck, North Dakota, 58501, United States

RECRUITING

Heart River Correctional Center (HRCC)

Bismarck, North Dakota, 58502, United States

RECRUITING

MeSH Terms

Conditions

Combat DisordersStress Disorders, Post-TraumaticAlcoholismSubstance-Related DisordersDepressionPsychological Well-BeingWounds and InjuriesStress Disorders, TraumaticRecidivism

Condition Hierarchy (Ancestors)

Trauma and Stressor Related DisordersMental DisordersAlcohol-Related DisordersChemically-Induced DisordersBehavioral SymptomsBehaviorPersonal SatisfactionCriminal Behavior

Study Officials

  • Melissa J Zielinski, PhD

    University of Arkansas

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Melissa J Zielinski, PhD

CONTACT

Mollee K Smith Steely, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 3, 2025

First Posted

April 11, 2025

Study Start

July 7, 2025

Primary Completion (Estimated)

December 1, 2028

Study Completion (Estimated)

December 1, 2028

Last Updated

January 21, 2026

Record last verified: 2026-01

Locations